FDA NDA · NDA214998
CAMZYOS
Sponsor: BRISTOL
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA214998
TYPE
NDA
ORIGINAL APPROVAL
2022-04-28
LATEST ACTION
2026-09-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
CAMZYOS · ReferencePrescription
MAVACAMTEN 2.5MG · CAPSULE · ORAL
CAMZYOS · ReferencePrescription
MAVACAMTEN 15MG · CAPSULE · ORAL
CAMZYOS · ReferencePrescription
MAVACAMTEN 5MG · CAPSULE · ORAL
CAMZYOS · ReferencePrescription
MAVACAMTEN 1MG · CAPSULE · ORAL
CAMZYOS · ReferencePrescription
MAVACAMTEN 10MG · CAPSULE · ORAL
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →